Abstract |
|
Authors | Masataka Sata, Hiroaki Nishimatsu, Jun-ichi Osuga, Kimie Tanaka, Nobukazu Ishizaka, Shun Ishibashi, Yasunobu Hirata, Ryozo Nagai |
Journal | Hypertension (Dallas, Tex. : 1979)
(Hypertension)
Vol. 43
Issue 6
Pg. 1214-20
(Jun 2004)
ISSN: 1524-4563 [Electronic] United States |
PMID | 15166180
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoproteins E
- Fatty Acids, Monounsaturated
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Indoles
- Pyridines
- Quinolines
- Fluvastatin
- cerivastatin
- Nitric Oxide Synthase
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Nos3 protein, mouse
- pitavastatin
|
Topics |
- Animals
- Apolipoproteins E
(deficiency, genetics)
- Arteriosclerosis
(chemically induced, etiology, genetics)
- Fatty Acids, Monounsaturated
(administration & dosage, pharmacology, therapeutic use)
- Femoral Artery
(surgery)
- Fluvastatin
- Hindlimb
(blood supply)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(administration & dosage, pharmacology, therapeutic use, toxicity)
- Hypercholesterolemia
(complications, genetics)
- Indoles
(administration & dosage, pharmacology, therapeutic use)
- Ischemia
(drug therapy, physiopathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Neovascularization, Pathologic
(chemically induced)
- Neovascularization, Physiologic
(drug effects)
- Nitric Oxide Synthase
(metabolism)
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Pyridines
(administration & dosage, pharmacology, therapeutic use, toxicity)
- Quinolines
(administration & dosage, pharmacology, therapeutic use)
|